- 2 Oregon practices merge, creating one of state’s largest physician-owned groups
- 3 states take aim at private equity in healthcare
- Google develops passive heart rate monitoring via smartphone camera
- Why AdventHealth thinks it can sell an internal health plan model to employers
- AHA: Hospitals lean on technology to make healthcare more affordable
- How Oceans Healthcare is scaling behavioral care — starting with the ER
- South Dakota health system names 2 executives
- LCMC Health commits $600K for New Orleans stadium naming rights
- How CRNA concentration varies by state
- Ohio State cancer center names chief medical officer
- ‘Never about getting bigger’: Sanford, North Memorial CEOs on what their deal means
- Integris names new CHRO
- Dana-Farber receives $50M gift
- 5 ASC leaders to know
- GLP-1 drugs tied to 75% lower substance use disorder odds: 4 notes
- When physician groups hit the wall: 3 turnaround stories
- 7 updates from Park Dental Partners since its IPO
- How general dentist pay compares to 25 healthcare roles
- 14 state behavioral health policy updates
- Who’s snatching up DSOs?
- The missed colonoscopy problem ASCs can no longer afford to ignore
- DEA finalizes OUD treatment rule: What it means for behavioral healthcare
- How Much Alcohol Is Actually Safe? A New Study Challenges Old Advice
- HCA Surgery Ventures names supply chain CEO
- 15 neurosurgeons to know
- CRNA pay is up 59% since 2019: 5 reasons why
- GLP-1s tied to lower risk of multiple cancers
- University of Pittsburgh dental school to open 3rd training center
- Colorado ‘screened out’ 92% of youth center abuse hotline calls: 5 things to know
- ASCs’ hidden efficiency drain
- Dental College of Georgia dean dies
- SF General, UCSF fined after social worker’s fatal stabbing
- Penn Medicine ED program boosts naltrexone prescriptions 15-fold
- Hundreds of hospitals warned over price transparency failings, AP reports
- Air Pollution Might Contribute To Clogged Arteries, Heart Disease Risk
- New Study Suggests No Major Adverse Outcomes With Early GLP-1 Exposure During Pregnancy
- Cleveland Clinic agrees to 'decades-long' halt on gender-affirming care for minors in DOJ settlement
- WuXi AppTec lands on Pentagon blacklist, facing Biosecure ban
- Merck, Gilead score in effort to develop the first weekly HIV pill
- As Gilead's Trodelvy stumbles in first-line lung cancer, all eyes turn to Merck, AZ and Daiichi rivals
- Clinicians report AI use expands patient capacity, boosts efficiency: Philips survey
- Feeding Babies Eggs Sooner May Cut Allergy Risk, Study Suggests
- At A Tennessee Hospital, Nurse Stole Fentanyl And AI Missed It, State Records Say
- Infections A ‘Major Health Hazard’ For People With Diabetes, Large Study Warns
- MAHA's Treatments For Autism: Camel's Milk, Stem Cell Injections — And Spelling Therapy
- Could Your Kid Benefit From Counseling? Experts Offer 3 Questions To Help You Decide
- Trivia Nights, Valentine’s Cards: Overlooked Social Connections Can Prevent Suicide
- AstraZeneca reprimanded over LinkedIn likes once again
- 29 behavioral health executive moves to know
- 3 states where dental hygienist pay dropped
- 5 states where dental assistant pay dropped
- ‘No disruptions’: Elevance study backs take-home methadone
- Federal workforce programs boost dental care accessibility: 5 notes
- Ultradent acquires dental laser manufacturer
- ADA Forsyth Institute ranks among top research institutions
- Dartmouth Health targets treatment gap for pregnant patients with SUD
- From affordability to engagement, these are the topics to watch at AHIP 2026
- Accrediting bodies, more medical schools commit to RFK Jr.'s nutrition education pledge
- Children's Well-Being Plummets Across 29 States, Report Finds
- Senate HELP committee chairman seeks info on NYC Health + Hospital data breach
- ADA: Lilly posts oral semaglutide-topping data as Foundayo speeds toward 2nd potential nod in diabetes
- With ADA in the books, analyst says Lilly is ‘widening its lead’ in the obesity race
- CVS launched an AI Learning Academy for its workforce. Here's why
- Just 5 Minutes Of Prayer Helps Reduce Pain and Anxiety, Study Finds
- Sophia Genetics, Memorial Sloan Kettering sign strategic collab for AI-powered precision oncology hub
- ‘Law & Order’ star Mariska Hargitay teams up with BMS to investigate multiple myeloma research in awareness campaign
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- ADA: Novo's Wegovy pill reaches new GLP-1 patients with impressive 3M prescription milestone
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- Cities sue Trump administration to block final ACA rule
- Irregular Sleep Risks Preschool Kids' Brain Power
- Why Alcohol Makes You Crave Salty Snacks — And How Protein-Rich Foods Can Help Prevent Weight Gain
- ADHD ‘Masking’ May Help People Blend In But Harms Mental Health
- Getting The RSV Shot, Abrysvo, While Pregnant Could Protect Your Baby After Birth
- Pfizer scores FDA pediatric expansion for hemophilia treatment Hympavzi
- Upcoming Billing Change Could Make Pregnancy Pricier
- MAHA’s Treatments for Autism: Camel’s Milk, Stem Cell Injections — And Spelling Therapy
- By September, Nearly a Third of Americans Will Live in States With Legal Aid in Dying
- Hikma earmarks $267M to expand pair of Ohio production sites, add 350 jobs
- Stepful banks $55M to scale AI-powered medical training to boost the workforce pipeline
- ADA: Amgen highlights Repatha perks, GLP-1 pitfalls in push to boost cardiometabolic pedigree
- Gounder Fills In Details Behind Ebola, GLP-1, and Trump Headlines
- Untreated Cancer, Festering Infections: Immigrant Detainees Detail Medical Care Lapses
- Elation Health acquires Aster as it ramps up agentic AI for primary care
- Dengue Is No Longer Just A Travel Risk — What Google’s Mosquito Plan Could Mean For Your Summer
- Brain Surgery For Pituitary Tumor Helps Illinois Mom Have Second Baby
- Essence Healthcare, Oura expand partnership to sleep apnea detection
- Takeda takes $2.5B legal charge after pay-for-delay verdict, swings to loss for '25
- Industry Voices—A healthcare experience that is as seamless as it is soulful
- Fullspan Health debuts Healthline AI companion to connect consumers to medical content and providers
- As pro-life pressure ramps up on Trump, FDA is investigating safety of abortion pill: WSJ
- As pro-life pressure ramps up on Trump, FDA is investigating safety of abortion pill: WSJ
- Popular Blood Pressure Meds, Dihydropyridine Calcium-Channel Blockers, Linked To Kidney Damage Risk In Type 2 Diabetes
- Too Much Sitting In Pregnancy Doubles Risk Of Complications
- Spinal Cord Stimulation May Restore Arm Strength After Stroke
- Behind the headlines of ASCO 2026
- RFK Jr. Seeks To Peek At Americans' Medical Records For Clues On Autism And Vaccines
- Two-Pill Combo, Inqovi and Venclexta, Offers Hospital-Free Leukemia Treatment Option For Older Adults With AML
- Millions of Kids Could Lose Insurance as GOP Healthcare Cuts Start To Bite
- Upcoming Billing Change Could Make Pregnancy Pricier
- ‘We Live With Fear’: In Congo, Doctors Face Ebola With Little Protection
- WellSpan Health strikes strategic partnership with Philips to deploy, co-develop new healthcare tech
- At first public hearing for FDA’s CNPV program, industry support meets ‘deep concern’ from experts
- “Harmonization: We’ll Have Lots to Talk About”
- Remarks at the Investor Advisory Committee Meeting
- A Quarter for your Thoughts: Remarks at the Meeting of the SEC Investor Advisory Committee
- Weekly Rundown: Trump signs AI executive order; Health Catalyst to sell Vitalware for $147M
- Small businesses feel the squeeze as healthcare costs rise: Morgan Health
- Poll Finds Broad Support For Stricter Regulations On Ultra-Processed Foods
- It's unanimous: SCOTUS agrees with Hikma in 'skinny label' case vs. Amarin
- Remarks at the Investor Advisory Committee Meeting
- Fierce Pharma Asia—China's biotech rise; ASCO highlights; Lilly pipeline deals
- Nearly 1 in 5 Young People Turn to AI Chatbots for Mental Health Advice
- Ixlayer rolls out digital acute pain management platform in collaboration with Vertex Pharmaceuticals
- Ixlayer rolls out digital acute pain management platform in collaboration with Vertex Pharmaceuticals
- ADC Therapeutics' shares plummet after patient deaths in trial of Zynlonta
- As China biotech crackdown calls reverberate in Washington, the pushback gets louder, too
- Older LGBTQ+ Adults Fear Less Support As They Age, Poll Shows
- Night Owls Are More Prone To Anxiety, Loneliness
- Home-Delivered Medical Meals Reduce ER Visits, Save Money
- Axsome fends off generic competition to narcolepsy med Sunosi until 2040
- Menopause Hormone Therapy Use Drops Sharply Across United States
- Michigan Found A Way To Reduce School Vaccine Waivers — Until It Backfired
- Listen to the Latest ‘KFF Health News Minute’
- Medline earns FDA warning letter ire for repeated toxic bacteria problems
- 8 Requirements for AI Medical Interpreting: 2026 Survey Results
- Healthcare Dealmakers—WakeMed to join Atrium Health, Qualtrics closes $6.8B Press Ganey deal and more
- Millions on Medicaid May Soon Have To Prove They’re Working To Keep Coverage
- Just 90 Minutes Of Strength Training A Week Linked To Longer Life
- Chemo-Free Drug, Tecvayli, Shows Major Survival, Remission Gains In Relapsed Multiple Myeloma
- Urine Test Can Detect Autism, Study Says
- High-Puff Vapes Become More Toxic Over Time, Study Says
- GLP-1 Drugs Like Ozempic May Lower Breast Cancer Risk By About 30%
- Telehealth Booms As Demand For GLP-1s Surges and Questions Mount About Safety, Oversight
- Base Case: Remarks at the IC3 Blockchain Camp
- Trump Signs Order Calling For Fewer Childhood Vaccines
- Simple Blood Test May Help Detect And Stage Alzheimer's Disease
- Smartphone App Helps Those With Advanced Cancer Maintain Quality Of Life
- Asthma Drug, Tezspire, Cuts Need For Steroid Pills While Keeping Attacks In Check
- Childhood Flu Shots Prevent Millions of Cases, Study Finds
- Commission Statement on the Passing of Former General Counsel David Becker
- MedTech In Focus: AI impact in healthcare
- If Your AI Can’t Explain Itself, Can FDA Authorize It?
- Climate Change: Statement on Proposed Rescission of Climate-Related Disclosure Rules
- Statement of Commissioner Mark T. Uyeda on the Rescission of Climate-Related Disclosure Rules
- Keynote Remarks at the 2026 Reagan National Economic Forum
- Statement on Proposing Release for Rescission of Climate-Related Disclosure Rules
- Privacy and PetShops: Remarks at the Regulatory PETshop Series: Cryptographic Technologies and Financial Services Regulation
- CAT on a Hot Tin Roof
Michigan healthcare freedom community forum
Malaysian-based Karex Bhd, the world's largest prophylactic manufacturer, plans to raise prices by 20% to 30+% according to its CEO, Goh Miah Kiat. Karex produces over five billion condoms annually, about one-fifth of the 25 billion condoms produced globally.
Karex's supply of precursor chemicals has become unreliable since the Strait of Hormuz closed and shipments to customers which previously took a month now take close to two months. It stands to reason that the same issues will affect the supply and pricing of nitrile gloves, which are a very similar product in terms of foreign producers, raw materials, and production processes:
World's top condom maker Karex to raise prices sharply as Iran war strains supply chain
By Rozanna Latiff - April 21, 2026KUALA LUMPUR, April 21 (Reuters) - Malaysia's Karex Bhd (KARE.KL), opens new tab, the world's top condom producer, plans to raise prices by 20% to 30% and possibly further if supply chain disruptions drag on due to the Iran war, its chief executive said on Tuesday.
Karex is also seeing a surge in condom demand as rising freight costs and shipping delays have left many of its customers with lower stockpiles than usual, CEO Goh Miah Kiat told Reuters in an interview.
"The situation is definitely very fragile, prices are expensive... We have no choice but to transfer the costs right now to the customers," Goh said.
Karex produces over 5 billion condoms annually and is a supplier to leading brands like Durex and Trojan, as well as state health systems such as Britain's NHS and global aid programmes run by the United Nations.
The condom maker joins a growing list of companies, including medical glove makers, bracing for supply chain bottlenecks as the Iran war strains energy and petrochemical flows from the Middle East, disrupting procurement of raw materials.
Since the conflict began in late February, Karex has seen costs increase for everything from synthetic rubber and nitrile used in manufacturing condoms to packaging materials and lubricants such as aluminium foils and silicone oil, Goh said.
He said Karex has enough supplies for the next few months and is looking to boost output to meet growing demand, as global stockpiles of condoms have dropped significantly following deep spending cuts in foreign aid, particularly by the U.S. Agency for International Development last year.
Demand for condoms has risen about 30% this year, with shipping disruptions further exacerbating shortages, he said.
Karex's shipments to destinations such as Europe and the United States are now taking close to two months to arrive, compared to a month previously.
"We're seeing a lot more condoms actually sitting on vessels that have not arrived at their destination but are highly required," Goh said, adding that a lot of developing countries do not have enough stock because it takes time for the products to reach them.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.





















